tiprankstipranks
Singular Health Group Ltd (AU:SHG)
ASX:SHG
Australian Market

Singular Health Group Ltd (SHG) Financial Statements

Compare
3 Followers

Singular Health Group Ltd Financial Overview

Singular Health Group Ltd's market cap is currently AU$64.58M. The company's EPS TTM is AU$-0.029; its P/E ratio is ―; Singular Health Group Ltd is scheduled to report earnings on February 21, 2025, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Jun 23Jun 22Jun 21Jun 20
Income Statement
Total RevenueAU$ 90.83KAU$ 616.14KAU$ 54.03KAU$ 193.64KAU$ 103.86K
Gross ProfitAU$ -2.67MAU$ -3.58MAU$ -2.11MAU$ -1.62MAU$ -669.39K
Operating IncomeAU$ -3.93MAU$ -5.09MAU$ -5.97MAU$ -2.99MAU$ -669.39K
EBITDAAU$ -2.89MAU$ -4.52MAU$ -5.72MAU$ -2.90MAU$ -637.00K
Net IncomeAU$ -4.92MAU$ -5.39MAU$ -5.99MAU$ -4.46MAU$ -707.59K
Balance Sheet
Cash & Short-Term InvestmentsAU$ 1.45MAU$ 691.51KAU$ 1.14MAU$ 4.14MAU$ 130.55K
Total AssetsAU$ 2.35MAU$ 3.00MAU$ 2.14MAU$ 5.43MAU$ 668.27K
Total DebtAU$ 218.45KAU$ 2.51MAU$ 85.66KAU$ 147.59KAU$ 745.94K
Net DebtAU$ -1.23MAU$ 1.82MAU$ -1.05MAU$ -3.99MAU$ 615.39K
Total LiabilitiesAU$ 909.59KAU$ 2.94MAU$ 391.50KAU$ 345.10KAU$ 881.86K
Stockholders' EquityAU$ 1.44MAU$ 61.89KAU$ 1.75MAU$ 5.08MAU$ -213.59K
Cash Flow
Free Cash FlowAU$ -2.51MAU$ -2.49MAU$ -2.92MAU$ -2.22MAU$ -807.48K
Operating Cash FlowAU$ -2.44MAU$ -2.46MAU$ -2.91MAU$ -1.91MAU$ -548.17K
Investing Cash FlowAU$ -3.56KAU$ -635.21KAU$ -17.12KAU$ -610.57KAU$ -259.31K
Financing Cash FlowAU$ 3.21MAU$ 2.65MAU$ -69.25KAU$ 6.52MAU$ 950.69K
Currency in AUD

Singular Health Group Ltd Earnings and Revenue History

Singular Health Group Ltd Debt to Assets

Singular Health Group Ltd Cash Flow

Singular Health Group Ltd Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis